Reuters logo
BRIEF-Medigene: U.S. patent office prolongs term of dendritic cell vaccines patent to 2031
May 28, 2015 / 5:52 AM / 2 years ago

BRIEF-Medigene: U.S. patent office prolongs term of dendritic cell vaccines patent to 2031

May 28 (Reuters) - Medigene AG :

* U.S. patent office prolongs term of Medigene’s patent relating to dendritic cell (DC) vaccines to 2031 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below